| GENE_SYMBOL |
DRUG_NAME |
Ki (nM) |
IC50 (nM) |
Kd (nM) |
EC50 (nM) |
Potency (nM) |
AC50 (nM) |
Datasource |
| F10 |
(17S,20R)-20-amino-N-[(4-carbamimidoylphenyl)methyl]-3,10,19-trioxo-2,5,8,11,18-pentazatetracyclo[20.2.2.25,8.212,15]triaconta-1(25),12,14,22(26),23,27-hexaene-17-carboxamide;2,2,2-trifluoroacetic acid |
113900 |
NA |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| F10 |
benzyl N-[(17S,20R)-17-[(4-carbamimidoylphenyl)methylcarbamoyl]-3,10,19-trioxo-2,5,8,11,18-pentazatetracyclo[20.2.2.25,8.212,15]triaconta-1(25),12,14,22(26),23,27-hexaen-20-yl]carbamate;2,2,2-trifluoroacetic acid |
104200 |
NA |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| F10 |
(17S,20R)-N-[(4-carbamimidoylphenyl)methyl]-20-(dimethylsulfamoylamino)-3,10,19-trioxo-2,5,8,11,18-pentazatetracyclo[20.2.2.25,8.212,15]triaconta-1(25),12,14,22(26),23,27-hexaene-17-carboxamide;2,2,2-trifluoroacetic acid |
134400 |
NA |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| F10 |
(19S,22R)-N-[(4-carbamimidoylphenyl)methyl]-3,12,21-trioxo-22-[(2-phenylacetyl)amino]-2,6,9,13,20-pentazatetracyclo[22.2.2.26,9.214,17]dotriaconta-1(27),14(30),15,17(29),24(28),25-hexaene-19-carboxamide;2,2,2-trifluoroacetic acid |
188400 |
NA |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| F10 |
(17S,20R)-N-[(4-carbamimidoylphenyl)methyl]-3,10,19-trioxo-20-[(2-phenylacetyl)amino]-2,5,8,11,18-pentazatetracyclo[20.2.2.25,8.212,15]triaconta-1(25),12,14,22(26),23,27-hexaene-17-carboxamide;2,2,2-trifluoroacetic acid |
201800 |
NA |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| F10 |
(19S,22R)-22-amino-N-[(4-carbamimidoylphenyl)methyl]-3,12,21-trioxo-2,6,9,13,20-pentazatetracyclo[22.2.2.26,9.214,17]dotriaconta-1(27),14(30),15,17(29),24(28),25-hexaene-19-carboxamide;2,2,2-trifluoroacetic acid |
404500 |
NA |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| F10 |
2-[[(2R)-2-(benzylsulfonylamino)-3-phenylmethoxypropanoyl]amino]acetic acid |
5500000 |
NA |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| F10 |
[2'-hydroxy-3'-(1H-pyrrolo[3,2-c]pyridin-2-yl)-biphenyl-3-ylmethyl]-urea |
125000 |
NA |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| F10 |
5-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]carbamoyl]-2-[2-[[4-(aminomethyl)phenyl]carbamoyl]-4-(methylamino)phenyl]benzoic acid |
NA |
200000 |
NA |
NA |
NA |
NA |
TTD |
| F10 |
(2S)-N-[(S)-{[(2S)-5-carbamimidamido-1-oxo-1-(1,3-thiazol-2-yl)pentan-2-yl]carbamoyl}(cyclohexyl)methyl]-2-({[(3,4-dichlorophenyl)methyl]carbamoyl}amino)-4-methylpentanamide |
NA |
200000 |
NA |
NA |
NA |
NA |
TTD |
| F10 |
(2S)-N-[(1S)-1-{[(2S)-5-carbamimidamido-1-oxo-1-(1,3-thiazol-2-yl)pentan-2-yl]carbamoyl}-2,2-dimethylpropyl]-2-({[(3,4-dichlorophenyl)methyl]carbamoyl}amino)-4-methylpentanamide |
NA |
200000 |
NA |
NA |
NA |
NA |
TTD |
| F10 |
(2S)-N-[(1S)-1-{[(2S)-5-carbamimidamido-1-oxo-1-(1,3-thiazol-2-yl)pentan-2-yl]carbamoyl}-2-methylpropyl]-2-acetamido-4-methylpentanamide |
NA |
200000 |
NA |
NA |
NA |
NA |
TTD |
| F10 |
[2-[(3,5-Dimethyl-1-phenylpyrazol-4-yl)amino]-2-oxoethyl] 2-(2-oxo-1,3-benzoxazol-3-yl)acetate |
NA |
200000 |
NA |
NA |
NA |
NA |
TTD |
| F10 |
[2-[(3,5-Dimethyl-1-phenylpyrazol-4-yl)amino]-2-oxoethyl] 2-phenylacetate |
NA |
200000 |
NA |
NA |
NA |
NA |
TTD |
| F10 |
[2-[(3,5-Dimethyl-1-phenylpyrazol-4-yl)amino]-2-oxoethyl] 2-(4-oxoquinazolin-3-yl)acetate |
NA |
200000 |
NA |
NA |
NA |
NA |
TTD |
| F10 |
FXIa-IN-8 |
NA |
340000 |
NA |
NA |
NA |
NA |
BindingDB |
| F10 |
4-[[(2S)-2-[[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]amino]-4-oxo-4-thiomorpholin-4-ylbutanoyl]amino]benzoic acid |
NA |
980000 |
NA |
NA |
NA |
NA |
BindingDB |
| F10 |
Diphenyl 1-(methylsulfonylamino)-2-(4-guanidinophenyl)-ethanephosphonate |
NA |
250000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| F10 |
Diphenyl 1-(benzoylamino)-2-(4-guanidinophenyl)-ethanephosphonate |
NA |
250000 |
NA |
NA |
NA |
NA |
TTD |
| F10 |
Substituted biphenyl derivative, 21 |
NA |
103000 |
NA |
NA |
NA |
NA |
BindingDB |